Vynleads (VYND) Net Income towards Common Stockholders (2020 - 2026)
Vynleads (VYND) posted Net Income towards Common Stockholders of -$96956.0 for Q1 2026, down 64.48% on a QoQ basis from -$58946.0 in Q4 2025, and down 19.74% YoY from -$120807.1 in Q1 2025.
Vynleads (VYND) Net Income towards Common Stockholders (2020 - 2026) Analysis & Trends
Vynleads (VYND) has reported Net Income towards Common Stockholders for 7 consecutive years, with -$96956.0 the latest figure, recorded in Q1 2026.
- For the quarter ending Q1 2026, Net Income towards Common Stockholders fell 19.74% year-over-year to -$96956.0; the trailing twelve-month figure through Mar 2026 stood at -$271052.0 (down 3.63% YoY), and the FY2025 full-year result was -$255066.0, up 2.35% from the prior year.
- Net Income towards Common Stockholders fell to -$96956.0 in Q1 2026 per VYND's latest filing, from -$58946.0 in the prior quarter.
- In the past five years, Net Income towards Common Stockholders ranged from a high of -$57081.0 in Q2 2025 to a low of -$96956.0 in Q1 2026.
- Median Net Income towards Common Stockholders over the past 5 years was -$62424.0 (2023), compared with a mean of -$67515.9.
- Annual changes were most pronounced in 2022 — Net Income towards Common Stockholders increased 17.33% — and 2026, when it retreated 19.74%.
- A 5-year view of Net Income towards Common Stockholders shows it stood at -$70858.0 in 2022, then rose by 14.78% to -$60383.0 in 2023, then fell by 5.41% to -$63647.0 in 2024, then advanced by 7.39% to -$58946.0 in 2025, then plunged by 64.48% to -$96956.0 in 2026.
- Per Business Quant, the three latest VYND Net Income towards Common Stockholders figures stand at -$96956.0 (Q1 2026), -$58946.0 (Q4 2025), and -$58069.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 24.83 Bn | 17.52 Bn | 662.02 Mn | 260.94 Mn |
| 2 | BrightSpring Health Services | 13.57 Bn | 12.69 Bn | 482.22 Mn | 74.33 Mn |
| 3 | Healthequity | 7.20 Bn | 6.93 Bn | 256.31 Mn | 69.42 Mn |
| 4 | Hinge Health | 5.42 Bn | 5.11 Bn | 154.23 Mn | 34.01 Mn |
| 5 | 10x Genomics | 4.46 Bn | 3.92 Bn | 106.18 Mn | -13.47 Mn |
| 6 | Doximity | 3.81 Bn | 3.06 Bn | 125.97 Mn | 19.11 Mn |
| 7 | Waystar Holding | 3.52 Bn | 3.36 Bn | 268.04 Mn | 43.32 Mn |
| 8 | Privia Health | 2.94 Bn | 2.57 Bn | 595.71 Mn | 3.71 Mn |
| 9 | Omnicell | 1.76 Bn | 1.59 Bn | 140.36 Mn | 11.41 Mn |
| 10 | Vynleads | - | - | -2,028.00 | -96,956.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -96,956.00 |
| Dec 31, 2025 | -58,946.00 |
| Sep 30, 2025 | -58,069.00 |
| Jun 30, 2025 | -57,081.00 |
| Mar 31, 2025 | -80,970.00 |
| Dec 31, 2024 | -63,647.00 |
| Sep 30, 2024 | -58,658.00 |
| Jun 30, 2024 | -58,271.00 |
| Mar 31, 2024 | -80,616.00 |
| Dec 31, 2023 | -60,383.00 |
| Sep 30, 2023 | -62,424.00 |
| Jun 30, 2023 | -66,063.00 |
| Mar 31, 2023 | -74,567.00 |
| Dec 31, 2022 | -70,858.00 |
| Sep 30, 2022 | -59,956.00 |
| Jun 30, 2022 | -58,118.00 |
| Mar 31, 2022 | -82,187.00 |
| Dec 31, 2021 | -75,728.00 |
| Sep 30, 2021 | -50,091.00 |
| Jun 30, 2021 | -70,304.00 |